The Role of IFNAR and MyD88 Signaling in Induction of IL-15 Expression In Vivo by Lefrancois, Leo et al.
University of Connecticut
OpenCommons@UConn
UCHC Articles - Research University of Connecticut Health Center Research
3-2012
The Role of IFNAR and MyD88 Signaling in
Induction of IL-15 Expression In Vivo
Leo Lefrancois
University of Connecticut School of Medicine and Dentistry, llefranc@neuron.uchc.edu
Sara L. Colpitts
University of Connecticut School of Medicine and Dentistry
Thomas A. Stoklasek
University of Connecticut School of Medicine and Dentistry
Courtney R. Plumlee
University of Connecticut School of Medicine and Dentistry
Joshua J. Obar
University of Connecticut School of Medicine and Dentistry
Follow this and additional works at: https://opencommons.uconn.edu/uchcres_articles
Part of the Life Sciences Commons, and the Medicine and Health Sciences Commons
Recommended Citation
Lefrancois, Leo; Colpitts, Sara L.; Stoklasek, Thomas A.; Plumlee, Courtney R.; and Obar, Joshua J., "The Role of IFNAR and MyD88
Signaling in Induction of IL-15 Expression In Vivo" (2012). UCHC Articles - Research. 161.
https://opencommons.uconn.edu/uchcres_articles/161
The role of IFNAR and MyD88 signaling in induction of IL-15
expression in vivo1
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†Howard Hughes Medical Institute, The Transgenic Unit at Janelia Farm Research Campus,
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Abstract
Interleukin-15 (IL-15) plays a multifaceted role in immune homeostasis, but the unreliability of
IL-15 detection has stymied exploration of IL-15 regulation in vivo. To visualize IL-15 expression,
we created a transgenic mouse expressing emerald-GFP (EmGFP) under IL-15 promoter control.
EmGFP/IL-15 was prevalent in innate cells including dendritic cells (DCs), macrophages, and
monocytes. However, DC subsets expressed varying levels of EmGFP/IL-15 with CD8+ DCs
constitutively expressing EmGFP/IL-15 and CD8− DCs expressing low EmGFP/IL-15 levels.
Virus infection resulted in IL-15 upregulation in both subsets. By crossing the transgenic mice to
mice deficient in specific elements of innate signaling, we found a cell-intrinsic dependency of
DCs and Ly6C+ monocytes on IFNAR expression for EmGFP/IL-15 upregulation after VSV
infection. In contrast, myeloid cells did not require the expression of MyD88 to upregulate
EmGFP/IL-15 expression. These findings provide evidence of previously unappreciated regulation
of IL-15 expression in myeloid lineages during homeostasis and following infection.
Introduction
Dendritic cells (DCs)5 and other antigen-presenting cells (APCs) such as macrophages help
maintain the homeostasis of immune cells. DCs produce the pleiotropic cytokine
interleukin-15 (IL-15), which binds the IL-15 receptor α (IL15Rα) chain intracellularly
(1,2). Using a unique mechanism termed transpresentation, the two proteins form a cell-
surface complex through which IL-15 is presented in trans to apposing cells that express
CD122 (the IL-2/15Rβ chain) and CD132 (the common γ chain) (1). Genetic deletion of
IL-15 or IL15Rα results in a lack of NK cells and the loss of most CD8+ memory T cells and
subsets of intestinal intraepithelial lymphocytes (IELs) (3,4). Specific deletion of IL-15Rα
within the CD11c+ DC population or the LysM+ macrophage population has a negative
impact on some populations of IL-15/IL-15Rα-dependent cells, but does not reduce any one
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population to the levels of complete knockout mice (5). Alternatively, limiting IL-15
expression to DCs can partially restore the defect within the NK cell and CD8+ memory T
cell populations but fails to rescue IEL subsets ((6)) that require IL-15 production
specifically from intestinal epithelial cells (7).
The mechanisms controlling the regulation of IL-15 remain largely unknown. Considering
the severe lymphoproliferation and immune activation that occurs in IL-15 transgenic mice
and mice treated with IL-15/IL-15Rα complex(8,9), it is perhaps not surprising that IL-15
expression is under tight transcriptional and translational control (10). Current methods for
detecting IL-15 directly ex vivo are limited and further complicated by the very short in vivo
half-life of soluble IL-15 (9,11), as well as the unique mechanism of IL-15
transpresentation. IL-15 expression is often measured by PCR detection of mRNA.
Alternatively, we and others have used ELISA to measure low levels of IL-15 in the sera of
mice and to detect the formation of IL-15:IL-15Rα complexes within the cell (2,9).
Detection of IL-15 by western blot or flow cytometry has proven difficult and robust
stimulation with TLR ligands is required to upregulate IL-15 to detectable levels (5,6).
Moreover, direct detection of IL-15 production by isolated cells ex vivo or in vivo has not
been documented in the literature thus heralding the need for a fresh approach. Therefore,
we utilized bacterial artificial chromosome (BAC) technology to generate a transgenic
mouse line in which emerald green fluorescent protein (EmGFP) is expressed under the
control of endogenous IL-15 regulatory elements. This system has allowed us to identify
cellular subsets with the potential to produce IL-15 and to visualize IL-15 regulation during
the generation of an immune response.
Materials and Methods
Mice
C57BL/6 mice were purchased from Charles River-NCI. Chimeric mice were generated by
i.v. injection of 2 × 106 bone marrow cells from donor mice into lethally irradiated (1000
rads) recipients. All mice were housed in accordance with the Animal Care Committee at the
University of Connecticut Health Center.
Generation of EmGFP/IL-15 reporter mice
The details regarding construction of these mice can be found in the Supplemental Figure 1
legend. EmGFP/IL-15 mice were further crossed to MyD88 KO mice (12) and IFNα
receptor 1 (IFNAR1) KO mice (13).
Flow cytometry and cell-sorting
5–10 × 106 cells were treated with Fc block followed by staining with the indicated
antibodies obtained from eBioscience, Biolegend, or BD Pharmingen and analysis on a BD
LSRII. Data were analyzed using FlowJo Software (Tree Star, San Carlos, CA). Sorting was
performed on a FACSAria following magnetic bead enrichment using MACS reagents
(Miltenyi Biotec).
VSV infection and in vivo antibody treatment
Mice were infected i.v. with 1.5 × 105 PFU of vesicular stomatitis virus (VSV). Where
indicated, mice were treated with 0.5mg anti-PDCA-1 (Miltenyi Biotec) i.v. 24 hours prior
to infection.
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Confocal microscopy
Spleens were sectioned using a scalpel and fixed in 2% PFA/PBS for 2 hrs at 4°C with
agitation, followed by additional washing in PBS (3X). Tissue samples were then incubated
with anti-B220 Alexa-647 (blue) in PBS/2% FBS/GS O/N at 4°C. Tissues were then washed
3X, mounted on slides, and analyzed by confocal microscopy (Zeiss LSM 510 Meta).
Spleen images were taken with a 20x/0.75 numerical aperture lens, and images were
analyzed using Imaris software (Bitplane).
Statistical analysis
Statistical significance was established by a One-way ANOVA test with a Tukey post-test
(GraphPad Prism). A p value of less than 0.05 was considered significant.
Results and Discussion
Generation of a BAC-EmGFP/IL-15 reporter mouse
In order to visualize cells with the potential to produce IL-15 in vivo, we generated a
transgenic mouse line in which EmGFP was introduced into the IL-15 locus. EmGFP was
inserted into exon 3 of the IL-15 gene contained in a BAC which effectively deleted the start
codon (Supplemental Figure 1).
EmGFP/IL-15 expression differs between DC subsets
The ability of DCs to produce and present IL-15 has been well documented (14). However,
in all instances, additional sources of stimulation are required to enhance IL-15 production
to detectable levels, and an analysis of IL-15 expression levels within different DC subsets
has not been performed (5,6). We initially characterized EmGFP/IL-15 expression in
individual DC subsets at steady state. Two major subsets of conventional DCs can be
identified in the spleens of naïve mice: CD8α+CD11b−DEC205+ and CD8α−CD11b+33D1+
DCs (15), referred to within as CD8+ and CD8− DCs, respectively. CD8− DCs expressed
low levels of EmGFP/IL-15 with some cells lacking expression, while CD8+ DCs expressed
significantly higher levels of EmGFP/IL-15 (Figure 1A). The differences in the mean
fluorescence intensities (MFI) of EmGFP/IL-15 expression accurately reflected differences
in IL-15 mRNA levels in these subsets as measured by real-time PCR (Supplemental Figure
2). CD11c− CD11b+ macrophages and monocytes also produced substantial levels of IL-15
(Figure 1B). Together, these results suggested that at steady state, IL-15 production is
largely limited to the CD8+ DC subset and CD11b+ macrophages and monocytes in the
spleen.
IL-15 is upregulated following VSV infection
Considering the ability of TLR ligands and inflammatory cytokines to upregulate IL-15 (14),
it is perhaps surprising that direct evidence for IL-15 upregulation in vivo is lacking.
Therefore, we asked what effect VSV infection had on IL-15 expression. Twenty-four hrs
post infection a significant increase in EmGFP/IL-15 expression in both CD8+ and CD8−
DCs was noted (Figure 2A and 2B). CD8+ DCs continued to express significantly increased
IL-15 levels over CD8− DCs (Figure 2B). The increase in EmGFP/IL-15 intensity within the
CD8+ DC subset over naïve controls corresponded to an upregulation in IL-15 mRNA
(Supplemental Figure 2). Thus, viral infection resulted in robust EmGFP/IL-15 induction in
DCs.
Since infection induced high EmGFP/IL-15 levels in DC, it was of interest to visualize this
response in situ. To this end, spleen sections from uninfected or VSV infected mice were
examined using confocal microscopy. In uninfected mice, EmGFP/IL-15 levels were
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generally low, but EmGFP/IL-15+ CD11c+ cells were observed in the red pulp and the T cell
zone, the periarteriolar lymphoid sheath (PALS), of the white pulp (Figure 2C). Twenty-four
hours after VSV infection, a dramatic increase in the number of EmGFP/IL-15+ cells as well
as in the intensity of EmGFP/IL-15 expression was observed in the spleen. EmGFP/IL-15+
cells appeared to be localized to the T cell zones, although EmGFP/IL-15+ cells were also
present in the red pulp (Figure 2C and unpublished observations). Therefore, the EmGFP/
IL-15 reporter system allowed the visualization of increased IL-15 promoter activity in
myeloid subsets following virus infection by ex vivo as well as in situ analysis.
IL-15 induction in response to virus infection is through IFNAR1-dependent and MyD88-
independent mechanisms
Both type I interferons (IFNs) and TLR signaling through MyD88 are known to induce
IL-15 (14). Furthermore, the ability of DCs to activate NK cells via IL-15 transpresentation
occurs in an IFN-dependent fashion following stimulation with TLR ligands (16). VSV
infection is also a potent inducer of type I IFN (17). To determine which factors were
involved in EmGFP/IL-15 we generated EmGFP/IL-15 mice lacking MyD88 or the type I
IFN receptor, IFNAR1. We compared the MFI of EmGFP/IL-15 in VSV-infected KOs to
groups of littermate controls that were (1) uninfected KO-EmGFP/IL-15 mice or (2) VSV-
infected mice heterozygous for expression of the gene in question. Between two independent
experiments, MyD88 KO-EmGFP/IL-15 mice upregulated EmGFP/IL-15 to the level of
heterozygous controls following VSV infection (Figure 3A). Upregulation was observed in
both CD8+ and CD8− DCs in addition to CD11b+Ly6C+ monocytes. However, for all
subsets, there was no difference in the MFI of EmGFP/IL-15 between VSV-infected IFNAR
KO mice and uninfected controls. Thus, IL-15 induction was IFNAR-dependent but
MyD88-independent following VSV infection.
In IFNAR KO mice, one could predict that downstream inflammatory mediators might also
be lacking following VSV infection when all cells are unable to signal via type I IFNs.
Therefore, we determined if direct signaling through the IFNAR was responsible for the
upregulation of IL-15 following VSV infection. To address this question, we generated
mixed bone marrow chimeras by reconstituting lethally irradiated WT mice (CD45.2) with
an equal mixture of bone marrow cells from IFNAR KO-EmGFP/IL-15 mice (CD45.1/
CD45.2) and WT-EmGFP/IL-15 (CD45.1) mice. Mixed chimeras from MyD88 KO-
EmGFP/IL-15 and WT-EmGFP/IL-15 bone marrow were also made to further support the
results described above. Chimeras were infected with VSV or not, and spleens were
harvested after 24 hours. In agreement with our observations in MyD88 KO-EmGFP/IL-15
mice, no significant defect in EmGFP/IL-15 upregulation was noted in mixed MyD88 KO
chimeras (Figure 4A). In contrast, IFNAR KO-EmGFP/IL-15-derived cells were unable to
upregulate EmGFP/IL-15 following infection (Figure 4B). These findings demonstrated that
cell-intrinsic IFNAR expression was required by DCs and monocytes for the upregulation of
IL-15 following VSV infection.
Lastly, we examined the source of type I IFNs following infection with VSV. Plasmacytoid
DCs (pDCs) produce large quantities of type I IFNs following viral infection, and previous
work suggests that pDCs are required for efficient production of IL-15 by conventional
(CD8+ and CD8−) DCs following CpG stimulation (18). To determine if pDCs functioned as
the primary source of IL-15-inducing type I IFNs following VSV infection, we treated mice
with α-PDCA-1 24 hrs prior to infection to deplete pDC (19). In all cell subsets examined,
pDC depletion significantly reduced EmGFP/IL-15 induction compared to controls (Figure
5). However, these subsets continued to produce significantly increased levels of EmGFP/
IL-15 over that of uninfected controls suggesting an alternative source of type I IFN
production in the absence of pDCs. Thus, both pDC-dependent and -independent effects
appear to regulate IL-15 induction in response to virus infection.
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Here, we have described a new BAC-EmGFP/IL-15 reporter mouse to track IL-15
expression. This system represents a major improvement over currently available IL-15
detection methodology, which cannot accurately identify ex vivo or in situ IL-15 expression
levels or the cell types expressing IL-15. Our results indicated that steady state levels of
EmGFP/IL-15 were distinct between unique DC subsets. For example, CD8+ DCs expressed
increased levels of EmGFP/IL-15 in comparison to the CD8− subset, the majority of which
lacked IL-15 at rest. Our findings differ from recent work by Stonier et al. in which the
authors used a polyclonal anti-murine IL-15 antibody to show low but comparable levels of
IL-15 on the surface of splenic CD8+ and CD8− DCs (6). However, analysis was performed
on splenocytes that were cultured overnight prior to analysis, which has the potential to
activate cells, and possibly upregulate IL-15. In our hands, consistent and convincing
staining of cells directly ex vivo for IL-15 has not been achievable (data not shown). A
higher level of steady-state IL-15 expression by CD8+ DCs suggested that this subset was
involved in homeostatic regulation mediated by IL-15. Moreover, the localization of CD8+
DCs to the T cell area suggests they may be pivotal in maintaining, for example, memory
CD8+ T cells following viral or bacterial infection under homeostatic conditions (20).
Previous studies have found that IL-15 can be induced by a number of inflammatory stimuli,
including cytokines and TLR ligands (14). The IL-15 promoter region contains several
known transcription factor consensus sites that could be activated via TLR pathways such as
NF-κB, ISRE, AP-1, GAS and IRF-E (21,22). Although injection of poly I:C or IFNα both
induce IL-15 in splenic DCs (14), whether virus infection has similar effects was not known.
In addition, which cell types might be induced to express IL-15 in response to infection had
not been examined. Our findings indicated that VSV infection significantly upregulated
IL-15 promoter activity as reported by EmGFP expression in both DC and monocyte
subsets, and IL-15 upregulation in splenic myeloid cells occurred independently of MyD88
expression. These findings are in contrast to previous reports in which intestinal epithelial
cells (iECs) required MyD88 for the expression of IL-15 and the maintenance of IL-15-
dependent IELs (23). Such differences in MyD88-dependency could reflect the dramatic
environmental differences experienced by iECs (parenchymal cells) and splenic APCs
(which are hematopoietic-derived). iECs are continuously exposed to commensal bacteria in
the absence of overt inflammation, and MyD88-mediated signaling could contribute to
constitutive IL-15 expression during steady state. Meanwhile, the inflammatory milieu of
the spleen following viral infection is under the influence of type I IFNs, and our data
indicate that cell-intrinsic IFNAR expression was required for the upregulation of IL-15 by
myeloid cells. In addition, while pDCs are considered a potent source of type I IFNs, their
expression of CD40L has been shown to support IL-15 upregulation in cDCs following CpG
exposure. Our finding that pDC depletion did not entirely ablate the ability of DCs and
monocytes to upregulate IL-15 suggests that reduced upregulation can occur independently
of pDC-cDC crosstalk following VSV infection. It is possible that (1) other cell types have
the ability to provide limited CD40-CD40L interactions or that (2) IL-15 upregulation can
occur entirely independent of CD40-CD40L engagement. It is also interesting to note that,
following VSV infection, the assistance of pDCs was provided independently of MyD88
expression. This is in contrast to the findings of Kato et al. in which MyD88 KO pDCs were
unable to produce IFN-α following in vitro infection with another negative sense ssRNA
virus, Newcaslte Disease virus (24). Thus, our findings suggest that in the absence of
MyD88, sufficient type I IFNs to upregulate IL-15 can be produced by other cell types,
likely of both parenchymal and hematopoietic origin, possibly through a RIG-I-dependent
mechanism (24).
In summary, our novel BAC-EmGFP/IL-15 transgenic reporter system has allowed us to
track endogenous IL-15 promoter activity during steady state conditions and inflammation.
Analysis of the reporter refined our understanding of constitutive and induced IL-15
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expression in myeloid subsets. Overall, the results suggested that IL-15 production is an
important and tightly regulated characteristic of innate immune cells.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. IL-15 is differentially expressed by DC subsets
(A) Spleens were harvested from transgenic mice (Tg+ : green line in histograms) or non-
transgenic littermate controls (Tg− : gray shaded histograms). T cells, B cells, and NK cells
were eliminated from the analysis by first gating on those cells negative for expression of
CD3, CD19 and NK1.1. Individual DC subsets were further identified using expression of
CD11c, MHC II, CD8α, CD11b, DEC205, and 33D1 as indicated above each histogram to
determine relative levels of EmGFP/IL-15 expression. A graphical representation of the
mean fluorescence intensity (MFI) of EmGFP/IL-15 for each population is shown in B.
EmGFP/IL-15 expression is shown for transgenic mice and non-transgenic controls. In all
scatter plots, one dot is indicative of the MFI from one mouse. (C) Splenic macrophages and
monocytes were identified by a CD11c−CD11bhigh phenotype. Flow cytometry plots are
shown from a single mouse and represent groups of 3–4 mice in more than 3 independent
experiments. * p < 0.05
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Figure 2. IL-15 is upregulated following VSV infection
(A-B) EmGFP/IL-15 transgenic mice were infected i.v. with 1.5 × 105 PFU VSV, and
spleens were harvested after 24hrs. EmGFP/IL-15 upregulation is shown on DC subsets
following infection (purple line) in comparison to uninfected controls (green shaded
histograms) in A with the MFI of EmGFP/IL-15 depicted graphically in B. (C) Thick
sections or whole mounts of spleen from transgene+ (naïve and VSV-infected) and
transgene− controls (naïve only) were stained with anti-B220 Alexa 647 (blue) and analyzed
by confocal microscopy. EmGFP/IL-15 is shown in green. Spleen images were obtained
with a 20x/0.75 NA lens and 40μm merged z-stacks are shown.
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Figure 3. IFNAR KO mice fail to upregulate IL-15 following VSV infection
EmGFP/IL-15 transgenics were subsequently crossed to MyD88 KO (A) and IFNAR1 KO
(B) mice. Experimental groups include (1) uninfected transgene+ KO mice [white bars], (2)
VSV-infected transgene+ KO mice [grey bars], and (3) VSV-infected transgene+ mice
expressing one copy of either MyD88 (A) or IFNAR1 (B) [grey bars]. A total of 5–6 mice
per group were pooled from 2 independent experiments. Data is presented as fold increase
over the average MFI of EmGFP/IL-15 in uninfected transgene+ KO controls. Bars indicate
mean ± S.E.M. Monocytes were defined as CD11b+Ly6C+ cells. * p < 0.05; not significant
(n.s.)
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Figure 4. IL-15 upregulation is dependent on cell-intrinsic IFNAR expression but independent of
MyD88
Mixed chimeras were generated from equal ratios of MyD88 KO-EmGFP/IL-15 and WT-
EmGFP/IL-15 bone marrow (A) or IFNAR KO-EmGFP/IL-15 and WT-EmGFP/IL-15 bone
marrow (B). Each group of cells was distinguished using CD45.1 versus CD45.2 expression.
Scatter plots depict the MFI of EmGFP/IL-15 in the indicated subsets of cells in the spleens
of uninfected (open circles/squares) and VSV-infected (closed circles/squares) mice. Each
dot is indicative of the MFI from one reconstituted mouse. 3–5 mice were used per group in
two independent experiments. * p < 0.05; not significant (n.s.)
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Figure 5. Reduced IL-15 upregulation in the absence of pDCs
Mice were treated with anti-PDCA-1 i.v. 24hrs prior to VSV infection. Control mice
remained uninfected or were infected with VSV but left untreated. Total splenocytes were
gated to exclude CD3+, CD19+, NK1.1+, and Ly6G+ cells before using CD11c, CD11b, and
CD8α to identify the three indicated populations as in Figure 1 and the relative levels of
EmGFP/IL-15 expression. The MFI of EmGFP/IL-15 is shown graphically in the scatter
plots for each population. Each dot corresponds to one mouse from one representative
experiment of three independent experiments. * p < 0.05
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